Integra LifeSciences IART Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Integra LifeSciences's operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Integra LifeSciences's operating lease right-of-use assets in other assets?
- Integra LifeSciences (IART) reported operating lease right-of-use assets in other assets of $137.2M in Q1 2026.
- How has Integra LifeSciences's operating lease right-of-use assets in other assets changed year-over-year?
- Integra LifeSciences's operating lease right-of-use assets in other assets decreased by 0.9% year-over-year, from $138.46M to $137.2M.
- What is the long-term trend for Integra LifeSciences's operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Integra LifeSciences's operating lease right-of-use assets in other assets has grown at a 10.9% compound annual growth rate (CAGR), from $83.64M to $140.57M.